A group of lawmakers spanning both parties and chambers is introducing legislation that would require insurance plans to cover genetic testing for patients with hereditary risk factors and expand education and outreach about gynecologic cancer risk. Sens. Elissa Slotkin (D-Mich.) and Katie Britt (R-Ala.) are leading the bill, the Ovarian Cancer IMPACT Act, which was...
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Bipartisan team in Congress looks to expand insurance coverage for ovarian cancer screening | 0 | 9.2 | 29-09-2026 |
| 2 | ACOG Strengthens Recommendation for Fallopian Tube Removal to Prevent Ovarian Cancer | 0 | 8.05 | 25-09-2026 |
| 3 | The UVM Cancer Center is scaling up its on-the-road efforts | 0 | 44.33 | 28-04-2026 |
| 4 | Aimee's Law advances out of committee, heading to Senate | 0 | 6.54 | 29-09-2026 |
| 5 | MIT researchers build cell collection device for early cancer detection | 0 | 10.41 | 24-09-2026 |
| 6 | Congress eyes slew of AI security proposals | 0 | 8.1 | 28-09-2026 |
| 7 | Insurance hinders home-injection program of breast cancer therapy | 0 | 10.14 | 24-09-2026 |
| 8 | FDA panel supports multicancer early detection test | 0 | 9.97 | 24-09-2026 |
| 9 | Mapping cancer’s genetic drivers: Sequencing, biomarkers and equity | 0 | 7.44 | 25-08-2026 |
| 10 | GSK presents positive data for B7-H4-targeted ADC in gynaecological cancers | 0 | 13.06 | 12-04-2026 |